Jay Soto

Parkinson disease

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model

Ageing as a risk factor for neurodegenerative disease

<p>Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics</p>

Design of amyloidogenic peptide traps

Therapeutic strategies for targeting neurodegenerative protein misfolding disorders

First‐in‐human assessment of PRX002, an anti–α‐synuclein monoclonal antibody, in healthy volunteers

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease